HEROLD OSBORNE: Open Payments
NPI 1710999727 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,564 in 128 payments from 16 companies in 2025. Trend: 2023 $1,485 · 2024 $2,313 · 2025 $2,564
Food & beverage: $2,298Education: $265
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $418 |
| Regeneron Healthcare Solutions, Inc. | 12 | $401 |
| ABBVIE INC. | 24 | $375 |
| GENZYME CORPORATION | 13 | $263 |
| Galderma Laboratories, L.P. | 11 | $190 |
| Lilly USA, LLC | 9 | $177 |
| UCB, Inc. | 10 | $150 |
| PFIZER INC. | 5 | $102 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $85 |
| Incyte Corporation | 4 | $82 |
Products named: DUPIXENT, TREMFYA, RINVOQ, NEMLUVIO, SKYRIZI, Bimzelx, TALTZ, OPZELURA.
Industry payments across TX — which companies pay providers there.
